Pharm Exam 3

0.0(0)
studied byStudied by 0 people
full-widthCall with Kai
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/38

flashcard set

Earn XP

Description and Tags

UNM NMNC 3230: Nursing Pharmacology

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

39 Terms

1
New cards

Aspirin

Class: NSAID

Use: pain relief + inhibits platelet aggregation

ADR: GI irritation, bleeding, Tinnitus with toxicity

Safety: Narrow therapeutic index, DO NOT GO OVER 4g/24hrs

Do not give to Peds → Reye’s syndrome

Give with full glass of water

2
New cards

Ibuprofen (Motrin, Advil)

Class: NSAID

Use: pain relief, reduces inflammation, and lowers fever.

ADR: GI irritation - ulcers <1%, CV disorders - with IV

Black Box warning – risk for CV (stroke + MI)+ GI events

Give w/ food or milk

Dosage 1200-2300 mg

3
New cards

Acetaminophen (Tylenol)

analgesic and antipyretic

little to no anti-inflammatory effects

ADR: Overdose → Liver Failure

MAXIMUM DAILY DOSE: 4g/24 hours

Overdose treatment → Acetylcysteine

4
New cards

Morphine

Class: opioid analgesic

Use: moderate/severe pain

ADR: respiratory depression, constipation, n/v, prutisis

5
New cards

Fentanyl

class: opioid analgesic (C-II)

  • 100X more potent that morphine

Use: induction of anesthesia, analgesia

ADR: respiratory depression, constipation, n/v, prutisis

  • higher incidence than morphine, esp. muscle rigidity

Elders: high risk of confusion

6
New cards

Oxycodone

class: opioid analgesic (C-II)

PO only

Use: moderate/severe pain

Popular drug of abuse

ADR: respiratory depression, constipation, n/v, prutisis

7
New cards

Hydromorphone (Dilaudid)

class: opioid analgesic (C-II)

  • 7X more potent than morphine

Use: analgesia

ADR: miosis, orthostatic hypotension, respiratory depression, itching/pruritis, constipation, N/V

8
New cards

Methadone

Class: synthetic opioid analgesic (C-II)

Use: detoxification treatment of opioid addicts in methadone maintenance programs

ADR: prolonged QT interval, constipation, respiratory depression

9
New cards

Buprenorphine

Class: opioid agonist-antagonist

Use: acute pain, chronic pain, opioid use disorder (OUD)

  • used to treat opioid addiction

ADR: similar to morphine with less respiratory depression, lower risk of abuse and addiction

can cause withdrawal in opioid dependent patients

10
New cards

Naloxone (Narcan)

Class: opioid antagonist

Use: partial or complete reversal of opioid induced respiratory depression, opioid overdose

ADR: Headache, Hypertension, Immediate reversal of opioid induced effects (pain, seizures, death)

reverse respiratory depression induced by an opioid

respiratory assessment

11
New cards

Allopurinol

Class: Anti-hyperuricemic agent

Use: prevents gout and lowers uric acid levels.

ADR: Pruritus, rash → discontinue, Bone marrow suppression

Asians at higher risk for severe skin reactions

12
New cards

Prednisone

Class: glucocorticoid (steroid)

Use: inflammatory diseases or conditions, allergies

MoA: inhibits inflammatory and immune responses

ADR: hypertension, psychosis, hyperglycemia, abdominal obesity

Take in the morning + DO NOT stop abruptly
*weakens immune system

*Adrenocortical insufficiency if stopped abruptly

13
New cards

Calcium Carbonate (Tums)

Class: Antacids

MoA: neutralizes gastric acid secretion and promotes gastric mucosal defense mechanisms

ADR: rebound hyperacidity, constipation, kidney stones

Safety: Interacts with absorption with other drugs; give 2-3 hours apart

  • when using as a Ca2+ supplement, take with Vitamin D for better absorption & efficacy

14
New cards

Magnesium Hydroxide

Class: Antacids

MoA: neutralizes gastric acid secretion and promotes gastric mucosal defense mechanisms

ADR: diarrhea

Safety: Interacts with absorption of other drugs: give 2-3 hours apart

  • not safe for patients with renal failure

15
New cards

Aluminum Hydroxide (Amphogel)

Class: antacid

MoA: neutralizes gastric acid secretion and promotes gastric mucosal defense mechanisms

ADR: Constipation

Safety: interacts with absorption of other drugs: give 2-3 hours apart

  • chronic use may elevate systemic aluminum levels

16
New cards

Antacids

Assessment: GI symptoms, renal function

Safety: Caution when given with other drugs. MANY drug interactions

Avoid long-term use

17
New cards

Histamine 2 Receptor Antagonists

MoA:

  • blocks H2 receptors of the acid-producing parietal cells

  • Less acid secretion occurs and gastric pH is raised

Common suffix: “-tidine”

Assessment: GI symptoms

Can be administered with ANTACIDS

Best taken at bedtime

18
New cards

Ranitidine (Zantac)

class: H2 blocker

Indications: GERD, Peptic Ulcer Disease (PUD), erosive esophagitis, stress ulcer prophylaxis

ADR: confusion, lethargy, and increased prolactin secretion

19
New cards

Proton Pump Inhibitors (PPI’s)

MoA: Block proton pump from secreting gastric acid

Common suffix: “-prazole”

Indications: GERD, stress ulcer prophylaxis, long-term treatment of hypersecretory conditions, with antibiotics for H. Pylori infections

Assessment: GI symptoms

Administration: dilute IV with sterile saline

  • PO or NG: do not crush or chew capsule or granules

20
New cards

Omeprazole (Prilosec)

class: PPI

ADR: myopathy and bone fracture (long-term use), associated with C. difficile infection

Administered PO or NG tube

  • Watch out for tube clogging!

21
New cards

Loperamide (Imodium)

Class: opiate antidiarrheal

MoA: decreases GI motility/peristalsis (antimotility)

ADR: low incidence (OTC)

Contraindications: ulcerative colitis, e. coli

22
New cards

Diphenoxylate & Atropine (Lomotil)

Class: Opiate antidiarrheal (atropine added to prevent abuse)

  • Rx only

MoA: decreases GI motility/peristalsis (antimotility)

Contraindicated: IBD (ulcerative colitis & crohn’s disease)

  • Higher risk of toxic megacolon

23
New cards

Psyllium (Metamucil)

Class: bulk-forming laxative

Indications: constipation (OTC)

MoA: fiber retains fluid, stimulates peristalsis

ADR: low incidence

Safety:

  • must be taken w/ LOTS of water to prevent obstruction or compaction

  • OK for long-term use

Take other meds 2 hours apart

24
New cards

Docusate (Colace, Soften, Docu-lax)

Class: Emollient laxative

Indication: Used to prevent constipation (OTC, PO)

MoA: Decreases surface tension of stool, allowing more water to enter.

  • Makes stool softer or lubricates the intestinal wall

ADR: Low incidence

25
New cards

Bisacodyl (Dulcolax, etc.)

Class: stimulant laxative

Indications: constipation, prep for GI procedures

  • OTC; Onset – Rectal 15 – 60 min, PO 6-12 hr

MoA: stimulates nerve endings to increase peristalsis

ADR: Cramps, GI distress, Laxative abuse

Stop use after 7 days

26
New cards

Meclizine (Antivert)

Class: antihistamine antiemetic

Indications: motion sickness, non-productive cough, allergy symptoms, sedation

MoA: H1 receptor blocker

  • inhibits ACh by binding to H1 receptors

  • prevents cholinergic stimulation in the vestibular region of the brain

ADR: Anticholinergic (drowsiness, tachycardia, urinary retention)

27
New cards

Metoclopramide (Reglan)

class: prokinetic antiemetic drug

Indications: prevention of nausea & vomiting, delayed gastric emptying, GERD

MoA: increased GI motility

Contraindications: seizure disorders, breast cancer, GI obstruction

ADR: EPS, tardive dyskinesia

PO and IV/IM

28
New cards

Ondansetron (Zofran)

Class: serotonin receptor blocker antiemetic

Indications: prevention of nausea and vomiting due to chemotherapy, radiotherapy, and surgery

MoA: blocks serotonin receptors in the GI, CTZ, VC

Suffix = -setron

ADR: Headache, Diarrhea, Prolonged QT interval

29
New cards

Rapid Acting Insulin

Lispro

Onset: 15 min, Peak: 1-2 hr, Duration 3-5 hr

“15 minutes feels like an hour during 3 rapid responses”

30
New cards

Short-acting insulin

Regular

Onset: 30 min, Peak: 2.5hr, Duration: 6-10 hr

Short staffed nurses went from 30 pts 2(to) 8 pts”

31
New cards

Intermediate acting insulin

NPH

Onset: 1-2 hr, Peak: 4-8 hr, Duration: 10-18 hr

Nurses Play Hero 2 8 16 yo”

32
New cards

Long-acting insulin

Glargine (NEVER mixed with anything else)

Onset: 1-2 hr, No peak, Duration: 24 hr
“The 2 long nursing shifts never peaked but lasted 24 hrs”

33
New cards

Insulins

Indications: Type 1 and Type 2 Diabetes Mellitus

MoA: substitute for endogenous insulin

  • metabolize carbohydrates, fats, and proteins

  • store glucose in the liver

  • convert glycogen to fat

ADR: HYPOGLYCEMIA (cBG’s), autonomic neuropathy, injection site reactions, lipodystrophy

HIGH ALERT DRUG

Only insulin allowed to give IV: Regular Insulin

Mixing: Clear (fast-acting) before Cloudy (long-acting) (not glargine)

SubQ ONLY + Rotate around site

34
New cards

Hypoglycemia Adverse Effects

Sweating, tremors, tachycardia, hunger, headache, impaired cognition, blurred vision, pallor, and seizures, disorientation, unconsciousness (more severe)

Treatment: give fruit juice, glucose tablet or other simple sugar

  • Severe: 50% Dextrose slow IV push over 3-5 mins

35
New cards

Metformin (Glucophage)

class: biguanide

indications: initial oral drug for prediabetes or type 2 diabetes

MoA: decreases hepatic glucose production, increases insulin sensitivity

ADR:

  • GI upset (n/v)

  • black box warning: lactic acidosis in patients with kidney problems; elders at increased risk

    • discontinue if Cr rises or will be receiving IV contrast

36
New cards

Glipizide (Glucotrol)

class: second generation sulfonylurea; oral antidiabetic drug

indication: type 2 diabetes mellitus

MoA: stimulates release of insulin from pancreatic beta cells

ADR: hypoglycemia, weight gain, photosensitivity

Safety: hypoglycemia risks

37
New cards

Pioglitazone (Actos)

 Class: oral antidiabetic, thiazolidinedione (“glitazone”)

Indication: type 2 diabetes, may be combined with other oral antidiabetic drugs or insulin

MoA: decreases insulin resistance by sensitizing insulin receptors

ADR: edema, weight gain, increased risk of fracture

Safety: black box warning - may worsen heart failure

38
New cards

GLP-1 agonists

”Glucagon-like peptide 1” = hormone

Secreted in response to food intake → release of insulin

Cause:

  1. increased insulin release

  2. decreased glucagon release

  3. decreased gastric emptying

  4. increased satiety

ADR: GI disturbances, weight loss, pancreatitis, medullary thyroid cancer, headache

Blood sugar GOAL: 60 – 120 mg/dL

39
New cards

Levothyroxine (Synthroid)

class: thyroid hormone replacement

MoA: mimics the effect of natural thyroid hormones

  • increases basal metabolic rate

  • affects temperature regulation

  • stimulation of the heart→increased cardiac output

  • increased renal blood flow

ADR

  • cardiac symptoms – tachycardia thru cardiac arrest

  • nausea, diarrhea

  • weight loss

Safety: do NOT use for weight control or weight loss

Give on an empty stomach & in AM